期刊文献+

表达HIV-1 gp160膜蛋白靶细胞的制备及鉴定 被引量:1

Preparation and Identification of Target Cells Expressing HTV-1 gp160 Membrane Protein
下载PDF
导出
摘要 目的获得表达INV-1 gp160膜蛋白的靶细胞,用于HIV-1特异性细胞毒性淋巴细胞(CTL)和抗HIV-1重组毒素细胞杀伤活性检测。方法采用PCR方法,从质粒pJen 10中扩增HIV-1 gp160基因,插入pGEM-T载体,测序后克隆入pIRESl neo载体中构建成重组质粒pIRE160,酶切鉴定正确后,转染人肝癌细胞(SMMG-7721),CA18加压筛选至细胞不再死亡为止,并采用Western blot和间接免疫荧光法对制备的靶细胞进行检测。结果HIV-1 gp160在SMMC7721表面表达,并裂解为gp120和gp41蛋白。结论已成功得到稳定表达HIV-1 gp160的靶细胞,且表达的蛋白具有良好的特异性。 Objective To obtain the target cells expressing HIV-1 gp160 membrane protein used for the determination of killing activities of HTV-1 specific cytotoxic T lymphocytes and anti-HTV-1 recombinant toxin cells.Methods Amplify HTV-1 gp!60 gene from plasmid pJen 10 by PCR, insert into pGEM-T vector, sequence and clone into pIRESl neo vector to construct a recombinant plasmid pIRE 160. Identify the recombinant plasmid by digestion with restriction endonuclease, transform to human hepatoma cell SMMC-7721 and subject to pressure screening with G418 until no death of cell occurs. Detect the prepared target cells by West-em blot and indirect immunofluorescence method. Results HTV-1 gp160 was expressed on the surface of SMMC7721 cells and lyzed into gp120 and gp41. Conclusion The target cells for stable expression of HIV-1 gp160 was successfully prepared, and the expressed protein showed good specificity.
出处 《中国生物制品学杂志》 CAS CSCD 2004年第3期155-157,共3页 Chinese Journal of Biologicals
基金 吉林省重点项目(20010404)资助.
  • 相关文献

参考文献2

  • 1萨姆布鲁克 弗里奇.分子克隆实验指南[M].北京:科学出版社,1992(第2版).956-957.
  • 2Robinson H L. New hope for an AIDS vaccine. Nature Review,2002,4: 239-250.

共引文献17

同被引文献11

  • 1赵博,金宁一,王瑞琳,郑敏,张应玖.SARS病毒核衣壳蛋白的表达与鉴定[J].高等学校化学学报,2005,26(11):2061-2065. 被引量:3
  • 2蒋静,赵丽辉,于湘晖,姜春来,吴永革,貌盼勇,李惟,孔维.HIV-1嵌合抗原的纯化及免疫原性分析[J].高等学校化学学报,2005,26(12):2259-2263. 被引量:2
  • 3ZHANG Lishu,JIN Ningyi,SONG Yingjin,SUN Yansong,WANG Hong,ZHAN Dawei,MA Hewen,SHANG Yupu,JIN Hongtao,HONG Baoqing,LI Chang.Immune responses of a designed HIV-1 DNA vaccine on rhesus monkeys[J].Chinese Science Bulletin,2006,51(13):1571-1577. 被引量:3
  • 4Ashore P. , Englund G. , Martin M. A. , et al.. J. Infect. Dis.[J] , 1991, 163:703-709
  • 5Seth H. Pincus. Antiviral Research[J], 1996, 33:1-9
  • 6Saavedra-Lozano J., Cao Y. , Callison J. , et al.. PNAS[J], 2004, 101(8) : 2494-2499
  • 7Pastan I., Chaudhary V., Fitz C, eralid D.. J. Annu. Rev. Bio. Chem. [J], 1992, 61:331-354
  • 8Quan-en Yang. Med. Sci. Monit. [J], 2004, 10(7) : RA155-165
  • 9Borst D. W., Betley M. J.. Infect. Immub. [J], 1993, 61(12) : 5421-5425
  • 10Abrahmen L., Dohlsten M., Segren S., et al.. EMBO J. [J], 1995, 14(13) : 2978-2986

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部